Article Text

Download PDFPDF
Systematic review with meta analysis
Existing evidence is insufficient to justify metformin or other agents as first-line therapy for type 2 diabetes

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Twitter Follow Victor Montori at @vmontori

  • Disclaimer The KER UNIT of the Mayo Clinic conducts research into shared decision-making, including the design and testing of shared decision-making tools, including the one cited in the commentary which is freely available. The authors derive no income from the use of this free tool:

  • Provenance and peer review Commissioned; internally peer reviewed.